Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GC Fuji IX is a high-viscosity, conventional glass ionomer restorative material designed for posterior restorations. It is characterized by its chemical adhesion to tooth structure (enamel and dentin) through an acid-base reaction with hydroxyapatite, eliminating the need for separate etching or bonding agents. The material is highly biocompatible and provides long-term fluoride release, which contributes to its anti-cariogenic properties and helps prevent secondary caries. In clinical practice, it is used for Class I and II restorations, core build-ups, and as a base or liner. In the context of studies conducted by institutions like the Liaquat University of Medical & Health Sciences, it is frequently evaluated for its performance in reducing postoperative sensitivity compared to resin-based composite materials.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on GC Fuji IX.